Q2-Header_1280x350_12

创新

推动持续改进

临床开发研究团队必须在制定和执行临床试验时面对许多挑战和复杂因素。我们已经部署了创新解决方案,并正在制定各种计划,支持我们的客户及其研究团队。

 

这些计划分为:

数字创新

在 Q2 Solutions,我们拥有专门的数字创新部门,专注于促进运营改善和服务质量提升。借助 BioFortis(Q2 Solutions 旗下公司)的 Labmatrix®  平台技术,我们以可追溯性、生产力、质量和效率为基础,帮助整个组织开发了敏捷而有影响力的解决方案。

 

Learn more

创新实验室

2021 年夏季,Q2 Solutions 启动了新的尖端定制设计实验室,并称之为 Q² Solutions 创新实验室。该设施位于新的 IQVIA 创新园,地处北卡罗来纳中部充满活力的三角研究园 (Research Triangle Park) 的中心,并创建了一个创新的科学社区,涵盖多个实验室学科,其服务领域包括 大分子生物分析, 疫苗卓越中心, 基因组学卓越中心转化科学与创新实验室 (TSAIL)

 

Learn more

Digital Innovation
exterior-600px

了解更多关于 Q2 Solutions 的信息


相关思想领袖见解


Through a CRO's Perspective: Innovative, Agile Solutions In Vaccine Efficacy Testing

The outbreak of the SARS-CoV-2 virus caused a sudden shift in focus for the pharmaceutical industry. After the genetic sequence of the virus was released in early 2020, manufacturers across the globe...

In vivo model design and assay selection to aid in progression from preclinical to clinical

Vaccine development is a complex path with multiple checkpoints and steps. In this presentation, we discuss the critical factors that must be assessed in the preclinical stage including: animal...

Considerations to select optimal functional assay for comprehensive vaccine efficacy data

In this presentation, we consider the available options to those looking to develop the best available assay to study vaccine efficacy. By focusing on the two types of immunity, researchers can...